| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |